Faculty Profiles - KANAZAWA Kenya

Papers - KANAZAWA Kenya

Division display201 - 220 of about 540／ All the affair displays >>

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine 10 ( 20 ) 6971 - 6984 2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine 10 ( 20 ) 6971 - 6984 2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine 10 ( 20 ) 6971 - 6984 2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine 10 ( 20 ) 6971 - 6984 2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine 10 ( 20 ) 6971 - 6984 2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine 10 ( 20 ) 6971 - 6984 2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine 10 ( 20 ) 6971 - 6984 2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine 10 ( 20 ) 6971 - 6984 2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine 10 ( 20 ) 6971 - 6984 2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine 10 ( 20 ) 6971 - 6984 2021.10

Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations.

Yamada Y, Imai H, Sugiyama T, Minemura H, Kanazawa K, Kasai T, Minato K, Kaira K, Kaburagi T

Medicina (Kaunas, Lithuania) 57 ( 9 ) 2021.9（ ISSN:1010-660X ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society 85 ( 5 ) 612 - 622 2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society 85 ( 5 ) 612 - 622 2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society 85 ( 5 ) 612 - 622 2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society 85 ( 5 ) 612 - 622 2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society 85 ( 5 ) 612 - 622 2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society 85 ( 5 ) 612 - 622 2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society 85 ( 5 ) 612 - 622 2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society 85 ( 5 ) 612 - 622 2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society 85 ( 5 ) 612 - 622 2021.4（ ISSN:1346-9843 ）

　 PREV - NEXT 　

<KANAZAWA Kenya>

Papers - KANAZAWA Kenya